Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
Clinical trial NCT05943990 · TERMINATED
Trial details
- NCT number
- NCT05943990
- Sponsor
- Adaptimmune
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2022-10-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.